
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
Institut National de la Santé et de la Recherche Médicale, INSERM U170, 94807 Villejuif, France [F. P., J. C., D. H.]; Institut National de la Santé et de la Recherche Médicale, Institute of Hematology, Saint-Louis Hospital, 75010 Paris, France [M-F. A.]; Department of Pediatric Hematology, Saint-Louis Hospital, Paris, France [A. B.]; Department of Pediatric Hematology, Armand Trousseau Hospital, Paris, France [G. L.]; Department of Pediatric Hematology-Oncology, Jeanne de Flandre Hospital, Lille, France [B. N.]; Department of Pediatric Hematology, Debrousse Hospital, Lyon, France [N. P.]; Department of Pediatric Hematology, Brabois Hospital, Nancy, France [D. S.]; and Department of Pediatric Hematology-Immunology, Robert Debré Hospital, Paris, France [E. V.]
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Patients and Methods |
|---|
|
|
|---|
11 years), gender, hospital, and ethnic origin using three categories (Caucasian, North African, and others). Of the mothers of the 282 cases and 291 controls who were eligible for interview during the interviewers working hours, the mothers of 2 cases and 2 controls refused to participate. One control child who was adopted, three control children for whom the questionnaires were incomplete, and one case child who was conceived with sperm from a sperm donor were excluded. Finally, a total of 279 incident cases of acute leukemia confirmed by cytology and 285 controls were included in the study. The mothers of the cases and controls were interviewed when the index child was in complete remission or in good condition (on average, 2 months after diagnosis), using a standard questionnaire administered by trained medical interviewers. Interviews were performed in the hospitals under strictly similar conditions and at the same time for the cases and controls. The questions addressed the sociodemographic characteristics, lifetime medical history of the index child, and smoking habits, beverage consumption, lifetime occupational history, and familial medical history of the parents. When mothers had lost contact with their relatives, the data were considered missing. Data were missing for three cases and three controls. The interviewers were not aware of the index childs family history before the interview. Familial medical history was collected for first-degree relatives (parents and siblings) and for second-degree relatives (grandparents, uncles, and aunts). Autoimmune diseases were systematically investigated for using a closed checklist including synonyms. Unfortunately, no medical validation of the diagnoses was available. The following diseases were considered autoimmune or potentially autoimmune: Graves disease and/or hyperthyroidism; Hashimotos thyroiditis and/or hypothyroidism; diabetes mellitus; rheumatoid arthritis; ankylosing spondylitis; multiple sclerosis; systemic lupus erythematosus; Behçets syndrome; Crohns disease; celiac disease; Landry-Guillain-Barré syndrome; and psoriasis.
Statistical analyses were performed using the SAS software package. The analyses were conducted by leukemia type (ALL3 versus ANLL). ORs were estimated using an unconditional logistic regression model including stratification variables (i.e., gender, age, ethnic origin, and hospital). Potential confounding by sociodemographic characteristics and familial structure was considered in the various analyses. A familial history of solid neoplasm or hematological neoplastic disease, for which the present authors had previously found an association with acute leukemia (5) , was also considered as potential confounder.
| Results |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
The hospital-based design of the study was chosen because case and control blood samples were required. Special care was therefore paid to selecting an appropriate control group. Controls were included from many diagnostic categories, none of which were related to the variables of interest. Sociodemographic characteristics and familial structure probably did not influence the results because they were very similar for the cases and controls, and adjustments for sociodemographic status and familial structure did not change the results.
Differential recall bias seems unlikely for first-degree relatives because a mother would be unlikely to omit or be unaware of a history of autoimmune disease in herself, her index childs father, or her children. The figures observed for the first-degree relatives histories of thyroid diseases are very similar to those observed for second-degree relatives and do not suggest differential recall bias. Another argument against differential recall bias for familial thyroid disease resides in the specificity of the results for potentially autoimmune thyroid diseases, compared with other thyroid diseases. However, a differential recall bias cannot be ruled out for the other diseases, mostly described for second-degree relatives, which may have been over declared by the cases mothers.
The associations between autoimmune disease and childhood leukemia reported in this paper were not explained by the history of cancer in first- or second-degree relatives, observed previously in the same study (5) . There was no case of thyroid cancer in the thyroid disease group.
For the rarest autoimmune diseases (i.e., rheumatoid arthritis, Crohns disease, multiple sclerosis, and even diabetes mellitus), the study suffered from a lack of power, which was increased by the fact that the relatives were young.
Associations between childhood leukemia and familial autoimmune diseases have been reported in several previous epidemiological studies. Till et al. (1) first reported that diseases selected as having a probable or possible autoimmune etiology in first- or second-degree relatives were significantly more frequent for children with leukemia than for the control children [OR = 2.3 (recalculated from the published data); P < 0.02; Ref. 1 ]. In that study, thyroid disorders such as thyrotoxicosis and myxedema were more frequent in cases than in controls [OR = 4.3 (recalculated from the published data); P = 0.01]. In a large case-control study, Buckley et al. (3) found a relationship between maternal multiple sclerosis and childhood acute lymphoblastic leukemia (relative risk, 4.0; 95% CI, 1.39.3). We did not observe that association in our study, but the numbers were very small. Woods et al. (2) found that cases reported a history of autoimmune disease among their maternal relatives more often than did controls, but the association was not statistically significant (relative risk, 1.76; P = 0.10).
An elevated incidence of acute leukemia before the age of 19 years has been reported among the offspring of men with diabetes mellitus in Denmark (SIR, 2.2; 95% CI, 1.02.6; Ref. 6 ), but our data for less than 15 children did not show that association. Finally, a case-control study conducted in children aged <18 months did not evidence any association between a family history of autoimmune diseases and childhood leukemia (7) , but the power of that study is also questionable because of the probable young age of the relatives.
To the best of the authors knowledge, there is currently no hypothesis for the mechanisms by which a familial history of familial autoimmune thyroid diseases may influence the risk of childhood leukemia. The association is observed with both second- and first-degree relatives and not only for mothers, and thus it does not suggest an association with disease-related medication use or a hormonal effect during pregnancy.
In short, the results reported herein suggest that a familial history of autoimmune thyroid disease may be involved in the etiology of childhood acute leukemia.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Supported by grants from INSERM, the French Ministère de lEnvironnement, the Association pour la Recherche contre le Cancer, the Fondation de France, the Fondation Jeanne Liot, the Fondation Weisbrem-Berenson, the Ligue Contre le Cancer du Val de Marne, and the Ligue Nationale Contre le Cancer. ![]()
2 To whom requests for reprints should be addressed, at INSERM U170, 16 avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France. ![]()
3 The abbreviations used are: ALL, acute lymphoblastic leukemia; ANLL, acute nonlymphoblastic leukemia; OR, odds ratio; CI, confidence interval. ![]()
Received 2/22/02; revised 10/ 9/02; accepted 10/28/02.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F Menegaux, A Baruchel, Y Bertrand, B Lescoeur, G Leverger, B Nelken, D Sommelet, D Hemon, and J Clavel Household exposure to pesticides and risk of childhood acute leukaemia Occup. Environ. Med., February 1, 2006; 63(2): 131 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Steffen, M F Auclerc, A Auvrignon, A Baruchel, K Kebaili, A Lambilliotte, G Leverger, D Sommelet, E Vilmer, D Hemon, et al. Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study Occup. Environ. Med., September 1, 2004; 61(9): 773 - 778. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |